No profile data available.
Can-Fite BioPharma Ltd. (CANF) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Ramat Gan, Israel, with about 5 full-time employees.
It reported revenue of $674,000 for fiscal year 2024, down 9.3% from fiscal year 2023, and net income of -$7.88 million. Its market capitalization was $7.80 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of December 4, 2025.
, a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis.
Can-Fite BioPharma reported $674,000 in revenue for fiscal year 2024, down 9.3% from $743,000 in fiscal year 2023.
$7.80 million as of December 4, 2025.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Mangoceuticals, Inc. (MGRX), Soligenix, Inc. (SNGX), Longeveron Inc. (LGVN), OSR Holdings, Inc. (OSRH).